Movement Alert|Teradyne Rises 8.37% in Regular Trading, Q2 Earnings Far Exceed Expectations as Investment Banks Raise Price Targets

Market Focus07-30 21:31

On July 30, Teradyne rose 8.37% in regular trading, trading at $349.93/share, with turnover of $73.26 million, extending post-earnings momentum.

On the news front, the company previously reported Q2 results that significantly beat market expectations. Q2 adjusted EPS came in at $2.47, far exceeding the consensus estimate of $2.09. Revenue reached $1.33 billion, up 104% year-over-year, surpassing the expected $1.22 billion. The semiconductor test segment contributed $1.122 billion, driven by surging AI chip testing demand. Net income reached $374.5 million, compared to $78.4 million in the year-ago period. Q3 guidance was equally robust, with revenue projected at $1.2 billion to $1.3 billion versus the Street estimate of $1.06 billion, and adjusted EPS midpoint of $2.00, well above the consensus of $1.44.

Additionally, multiple investment banks raised their price targets: JPMorgan adjusted to $465 from $450 maintaining Overweight, Cantor Fitzgerald raised to $550 from $400 maintaining Overweight, and UBS lifted to $500 from $440 maintaining Buy, reflecting strong institutional confidence in AI-driven growth prospects.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment